RivaroxabanA Review of its Use for the Prophylaxis of Venous Thromboembolism after Total Hip or Knee Replacement Surgery

被引：0
作者：
Sean T. Duggan
机构：
[1] Adis,
来源：
American Journal of Cardiovascular Drugs | 2012年 / 12卷
关键词：
Enoxaparin; Rivaroxaban; Total Knee Replacement; Enoxaparin Sodium; Prothrombin Complex Concentrate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Rivaroxaban (Xarelto®), an oral oxazolidinone-based anticoagulant, is a potent, selective, direct inhibitor of factor Xa that is used in the prevention of venous thromboembolism (VTE) in adult patients after total hip replacement (THR) or total knee replacement (TKR) surgery.
引用
收藏
页码：57 / 72
页数：15
相关论文
共 163 条
[31]  
Kubitza D.(2009)In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans Drug Metab Dispos 37 1046-8
[32]  
Becka M.(2009)Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans Drug Metab Dispos 37 1056-81
[33]  
Wensing G.(2006)Oral, direct factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement J Thromb Haemost 4 121-86
[34]  
Mueck W.(2006)A once-daily, oral, direct factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement Circulation 114 2374-75
[35]  
Becka M.(2005)BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement A phase II dose-ranging study. J Thromb Haemost 3 2479-86
[36]  
Kubitza D.(2008)Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty N Engl J Med 358 2765-80
[37]  
Mueck W.(2008)Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty N Engl J Med 358 2776-9
[38]  
Borris L.C.(2009)Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty Lancet 373 1673-44
[39]  
Dahl O.E.(2008)Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial Lancet 372 31-53
[40]  
Mueck W.(2009)Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement J Bone Joint Surg Br 91 636-70
12345678910